A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease
Clinical trial NCT03099187 · COMPLETED
Trial details
- NCT number
- NCT03099187
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-15
- Primary completion
- 2018-11-21
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.